Download PDF
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children
Wilson Toyohiro Hoshino; Adriana Maria Paixão De Sousa da Silva; Antonio Carlos Pignatari; Ana Cristina Gales; Fabianne Carlesse;
10.1016/j.bjid.2025.104515
Emergency and persistence of Escherichia coli ST131 as community-onset antimicrobial resistant urinary tract infection in Rio de Janeiro, Brazil
Eduardo Moreira de Castro; Isadora Silva Barcellos; Guilherme Santoro-Lopes; Ana Paula de Souza da Silva; Luís Guilherme de Araújo Longo; Mariana Anjo Barbosa; Gabriela Camarano de Oliveira; Lucas Cecílio Vilar; Adriana Lúcia Pires Ferreira; Karla Rodrigues Miranda; Beatriz Meurer Moreira;
10.1016/j.bjid.2025.104555
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015¿2020
Mark G. Wise; James A. Karlowsky; Elkin V. Lemos-Luengas; Rafael R. Valdez; Daniel F. Sahm;
Braz J Infect Dis. 2023;27: